Cardiology
AI echocardiogram model could speed cardiac amyloid diagnosis, expanding access in underserved settings.
High AIP linked to greater carotid atherosclerosis risk and progression, study finds.
Colchicine lowered arrhythmia, thrombosis after TAVR, but stroke risk led to early trial halt.
Dr. Kohli highlights the benefits of early, sustained LDL lowering for greater cardiovascular risk reduction and prevention.
High blood pressure and BMI will drive the global CVD burden through 2050, despite declines in age-standardized DALY rates.
In older AFib patients, bleeding raises death risk 4x, stroke nearly 2x—highlighting treatment complexities.
New AHA risk tool may underestimate heart disease in some groups, highlighting need for more accurate, equitable prediction.
Heart risk factors like high LDL and belly fat may weaken brain memory networks, new Alzheimer’s study finds.
Non-statin therapies key for high-risk patients not at LDL goal, says Dr. Kohli; advocates broader risk assessment.
Survival after OHCA has improved over 20 years, driven by more bystander CPR and early defibrillator use.
Delayed hypertension diagnosis lowers treatment rates and raises long-term cardiovascular risk, new study shows.
New study confirms Greek HeartQoL questionnaire is valid to assess quality of life in ischemic heart disease patients.
Topological data analysis may transform coronary plaque imaging and risk prediction.
Cancer diagnosis and atrial fibrillation are strongly linked; heart monitoring is crucial especially soon after diagnosis.
Poor sleep predicts long-term heart risks in menopausal women, study shows—reinforcing sleep as a key health metric.
Study finds diet-driven gut changes could improve hypertension control in older adults.
New NIH-backed research aims to safely gene-edit HCM, the world’s most common—and often undiagnosed—genetic heart ...
A new tech-based system flagged poor BP med use but didn’t improve adherence or lower BP more than usual care.
Genetic study uncovers fat metabolism genes that may explain the link between NAFLD and coronary artery disease.
SGLT2i use remains low in US heart failure care, despite proven benefits, with wide variation across clinics.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.